Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MSRD-100
DRUG
2 trials
Sponsors
Merz North America, Inc.
Conditions
Atopic Dermatitis
Phase 3
Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
Withdrawn
NCT02677636
Merz North America, Inc.
Atopic Dermatitis
Updated: 2016-09-09
Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older
Withdrawn
NCT02677610
Merz North America, Inc.
Atopic Dermatitis
End: 2017-03-31
Updated: 2016-09-09